EvolutionaryScale, an AI startup pioneering the 'ChatGPT moment for biology', is at the forefront of transforming the field with its ground-breaking technology. Backed by Amazon Web Services and NVIDIA's venture capital arm, the company aims to revolutionize biology through artificial intelligence.
Central to EvolutionaryScale's mission is ESM3, the first large language model for creating novel proteins. It leverages a vast dataset of nearly 2.8 billion proteins, plus computational tools that analyze protein sequence, structure and function simultaneously. This can help accelerate drug discovery, as well as enable sustainable solutions through engineered microbes.
EvolutionaryScale's approach should help accelerate scientific breakthroughs and enhance precision in biotechnological applications. The company's success hinges on its ethical use of AI to tackle these challenges, by accelerating protein engineering beyond natural evolution so that it can be put to use against our greatest problems.
Steph
Company Specialist at Welcome to the Jungle